Minimally invasive total knee arthroplasty.

Minimally invasive total knee arthroplasty using the contralateral knee as a control group: a case-control study. Int Orthop (2009) 1.57

Peri-operative interventions producing better functional outcomes and enhanced recovery following total hip and knee arthroplasty: an evidence-based review. BMC Med (2013) 1.08

Computer navigation-assisted versus minimally invasive TKA: benefits and drawbacks. Clin Orthop Relat Res (2008) 0.99

Minimally invasive total knee arthroplasty improves early knee strength but not functional performance: a randomized controlled trial. J Arthroplasty (2012) 0.98

Total knee arthroplasties performed with a mini-incision or a standard incision. Similar results at six months follow-up. BMC Musculoskelet Disord (2010) 0.95

Navigation did not improve the precision of minimally invasive knee arthroplasty. Clin Orthop Relat Res (2008) 0.89

Patellar tracking and anterior knee pain are similar after medial parapatellar and midvastus approaches in minimally invasive TKA. Clin Orthop Relat Res (2013) 0.88

Does tranexamic acid save blood in minimally invasive total knee arthroplasty? Clin Orthop Relat Res (2011) 0.87

Functional and radiological outcome after total knee replacement performed with mini-midvastus or conventional arthrotomy: controlled randomised trial. Int Orthop (2008) 0.86

Minimally invasive total knee arthroplasty: is it for everybody? HSS J (2006) 0.81

Minimally invasive total knee arthroplasty: surgical implications for recovery. J Knee Surg (2012) 0.80

Is minimally invasive total knee arthroplasty associated with lower costs than traditional TKA? Clin Orthop Relat Res (2010) 0.78

Minimally invasive total knee arthroplasty: a comparative study to the standard approach. N Am J Med Sci (2012) 0.78

Does minimally invasive total knee arthroplasty improve isokinetic torque? Clin Orthop Relat Res (2012) 0.78

A perspective on robotic assistance for knee arthroplasty. Adv Orthop (2013) 0.76

Mini-midvastus total knee arthroplasty does not result in superior gait pattern. Knee Surg Sports Traumatol Arthrosc (2014) 0.75

Computer-assisted total knee arthroplasty using mini midvastus or medial parapatellar approach technique : A prospective, randomized, international multicentre trial. BMC Musculoskelet Disord (2016) 0.75

Failure of the Patellar Tendon with the Patella Everted versus Noneverted in a Matched-Pair Cadaver Model. HSS J (2010) 0.75

Midterm outcomes of electromagnetic computer-assisted navigation in minimally invasive total knee arthroplasty. J Orthop Surg Res (2013) 0.75

Minimally invasive and computer-assisted total knee arthroplasty versus conventional technique: a prospective, randomized study. Eur J Orthop Surg Traumatol (2013) 0.75

New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res (2011) 5.59

Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res (2004) 3.80

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes (2006) 3.31

Economic Considerations for Obese Patients Undergoing Total Knee Arthroplasty: Commentary on an article by Eric R. Wagner, MD, et al.: "Effect of Body Mass Index on Reoperation and Complications After Total Knee Arthroplasty". J Bone Joint Surg Am (2016) 2.77

Anthropometric measurements of the human knee: correlation to the sizing of current knee arthroplasty systems. J Bone Joint Surg Am (2003) 2.53

Osteonecrosis of the hip: management in the 21st century. Instr Course Lect (2003) 2.42

Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano (2008) 2.41

Modular taper junction corrosion and failure: how to approach a recalled total hip arthroplasty implant. J Arthroplasty (2013) 2.13

Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop (2008) 2.00

Hip resurfacing arthroplasty. J Am Acad Orthop Surg (2006) 1.95

The ACL in the arthritic knee: how often is it present and can preoperative tests predict its presence? Clin Orthop Relat Res (2013) 1.90

The outcome of total knee arthroplasty in obese patients. J Bone Joint Surg Am (2004) 1.87

Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin. J Bone Joint Surg Am (2010) 1.79

Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J Biol Chem (2012) 1.79

Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am (2011) 1.79

Femoral neck fractures after metal-on-metal total hip resurfacing: a prospective cohort study. J Arthroplasty (2007) 1.75

Gait analysis of patients with resurfacing hip arthroplasty compared with hip osteoarthritis and standard total hip arthroplasty. J Arthroplasty (2007) 1.74

Hip arthroplasty. Lancet (2012) 1.73

Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia. ACS Nano (2011) 1.63

Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res (2008) 1.63

Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc (2012) 1.61

Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res (2005) 1.60

Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J Biol Chem (2001) 1.58

Minimally invasive total knee arthroplasty using the contralateral knee as a control group: a case-control study. Int Orthop (2009) 1.57

Total hip arthroplasties: what are the reasons for revision? Int Orthop (2007) 1.55

Procoagulants and osteonecrosis. J Rheumatol (2003) 1.54

Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem (2007) 1.52

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res (2008) 1.51

Total knee arthroplasty in obese patients: a comparison with a matched control group. J Arthroplasty (2004) 1.49

Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy. Autophagy (2011) 1.44

Do ceramic femoral heads reduce taper fretting corrosion in hip arthroplasty? A retrieval study. Clin Orthop Relat Res (2013) 1.44

Total hip arthroplasty: comparison of two-incision and standard techniques at an AOA-accredited community hospital. J Am Osteopath Assoc (2010) 1.43

Intraoperative waste of trauma implants: a cost burden to hospitals worth addressing? J Orthop Trauma (2009) 1.43

Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res (2012) 1.40

Revision total hip arthroplasty in Jehovah's Witnesses. Orthopedics (2012) 1.40

Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am (2008) 1.37

Initial experience with custom-fit total knee replacement: intra-operative events and long-leg coronal alignment. Int Orthop (2008) 1.36

Cementless femoral fixation in total hip arthroplasty. J Bone Joint Surg Am (2011) 1.33

Characterization of insulin signaling in rat retina in vivo and ex vivo. Am J Physiol Endocrinol Metab (2003) 1.29

Biographical sketch: Themistocles Gluck (1853-1942). Clin Orthop Relat Res (2011) 1.28

Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther (2003) 1.28

Survival of hard-on-hard bearings in total hip arthroplasty: a systematic review. Clin Orthop Relat Res (2011) 1.28

Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res (2003) 1.25

Failure to resurface the patella during total knee arthroplasty may result in more knee pain and secondary surgery. Clin Orthop Relat Res (2005) 1.24

Rapid distribution of liposomal short-chain ceramide in vitro and in vivo. Drug Metab Dispos (2008) 1.24

Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery. Nano Lett (2008) 1.23

American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am (2012) 1.23

Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther (2011) 1.22

Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin Cancer Res (2008) 1.22

Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: a systematic literature review. Int Orthop (2010) 1.21

Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels. J Lipid Res (2009) 1.21

Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res (2010) 1.21

Displaced femoral neck fractures in the elderly: hemiarthroplasty versus total hip arthroplasty. J Am Acad Orthop Surg (2006) 1.21

Functional problems and arthrofibrosis following total knee arthroplasty. J Bone Joint Surg Am (2007) 1.21

Arthrodesis of the knee. J Bone Joint Surg Am (2004) 1.19

Toll-like receptors at the ocular surface. Ocul Surf (2008) 1.18

Sports activity after total hip and knee arthroplasty : specific recommendations concerning tennis. Sports Med (2006) 1.17

Clinical experience using a minimally invasive surgical approach for total knee arthroplasty: early results of a prospective randomized study compared to a standard approach. J Arthroplasty (2007) 1.16

Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT. PLoS One (2007) 1.15

Minimally invasive total knee arthroplasty: a 10-feature evolutionary approach. Orthop Clin North Am (2004) 1.14

Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy. Diabetes (2006) 1.13

Nanoparticulate alternatives for drug delivery. ACS Nano (2010) 1.13

Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway. Am J Physiol Cell Physiol (2010) 1.12

Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis. Clin Orthop Relat Res (2008) 1.11

Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood (2010) 1.09

Serological markers can lead to false negative diagnoses of periprosthetic infections following total knee arthroplasty. Int Orthop (2010) 1.09

Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J Bone Joint Surg Am (2004) 1.09

Reduced dislocation rates and excellent functional outcomes with large-diameter femoral heads. J Arthroplasty (2013) 1.08

Advance pre-operative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop (2010) 1.08

Instability after total hip arthroplasty: treatment with large femoral heads vs constrained liners. J Arthroplasty (2008) 1.06

Cementless bipolar hemiarthroplasty for displaced femoral neck fractures in the elderly. J Arthroplasty (2004) 1.06

Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty (2010) 1.05

What's new in total hip arthroplasty. J Bone Joint Surg Am (2008) 1.05

Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res (2004) 1.05

Static progressive stretch improves range of motion in arthrofibrosis following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc (2009) 1.05

Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty. Int Orthop (2010) 1.05

What's new in total hip arthroplasty. J Bone Joint Surg Am (2011) 1.04

The appropriate use of patellofemoral arthroplasty: an analysis of reported indications, contraindications, and failures. Clin Orthop Relat Res (2005) 1.04

Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia. Blood (2011) 1.03

Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am (2008) 1.03

The effects of obesity and morbid obesity on outcomes in TKA. J Knee Surg (2013) 1.02

Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma. Gut (2010) 1.02

Formation and role of exosomes in cancer. Cell Mol Life Sci (2014) 1.02

Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma. Ann Pharmacother (2011) 1.02

Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices (2008) 1.01

The incorporation of morselized bone grafts in cementless acetabular revisions. Clin Orthop Relat Res (2004) 1.01

Function and fixation of total hip arthroplasty in patients 25 years of age or younger. Clin Orthop Relat Res (2010) 1.01

State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy. Am J Physiol Cell Physiol (2009) 1.00

Resurfacing versus conventional total hip arthroplasty - review of comparative clinical and basic science studies. Bull NYU Hosp Jt Dis (2009) 1.00

Total knee arthroplasty using cementless keels and cemented tibial trays: 10-year results. Int Orthop (2008) 1.00

Computer navigation-assisted versus minimally invasive TKA: benefits and drawbacks. Clin Orthop Relat Res (2008) 0.99

Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling. Arch Biochem Biophys (2005) 0.99